echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > newest! 20 cancer prevention methods released! To those who care

    newest! 20 cancer prevention methods released! To those who care

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    < br / >, The 2020 version of < br / > < br / > recommendation on screening and prevention of common malignant tumors of residents has been released < br / > < br / > advocating the "three early" concept of early detection, early diagnosis and early treatment < br / > < br / > 2020 version of recommendation on screening and prevention of common malignant tumors of residents < br / > < br / > compared with the 2019 version, In the 2020 edition of the recommendation, six new types of malignant melanoma, bladder cancer, ovarian cancer, bone tumor, soft tissue sarcoma and leukemia have been added, covering the prevention, early diagnosis and early treatment information of 20 kinds of common malignant tumors, among which six kinds of tumors, colorectal cancer, breast cancer, liver cancer, gastric cancer, thyroid cancer and esophageal cancer, have been updated on the original basis< br / > < br / > people over 40 years old who have two weeks of anorectal symptoms (referring to any of the following symptoms that last for more than two weeks: change of stool habits (constipation, diarrhea, etc.); change of stool shape (thin stool); change of stool nature (blood, mucus stool, etc.); pain in fixed part of abdomen); < br / > < br / > patients with ulcerative colitis for a long time; < br / > < br / > people after colorectal cancer surgery; < br / > < br / > colorectal adenoma treated population; < br / > < br / > immediate family member with family history of colorectal cancer; < br / > < br / > immediate family member diagnosed as hereditary colorectal cancer (referring to familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC)), age over 20 years old< br / >< br / >, Enteroscopy is performed once every five years; < br / > < br / > (2) high risk objects with family history of first degree relatives (only one, and the age of onset is higher than 60 years): screening begins at the age of 40, FOBT is performed once a year, and enteroscopy is performed once every ten years< br / > < br / > screening of "hereditary colorectal cancer" family members in line with 7: for the family members of FAP and HNPCC patients, when the gene mutation of the first case in the family is clear, it is recommended to carry out gene mutation detection< br / > < br / > (1) after the age of 20, the patients with positive gene mutation should be examined by enteroscopy every 1-2 years; the patients with negative gene mutation should be screened according to the general population< br / >< br / >, It may reduce the risk of cardiovascular and cerebrovascular diseases and colorectal cancerConsult a doctor for specific use; < br / > < br / > quit smoking to avoid its long-term toxicity and inflammatory stimulation to the digestive tract< br / > < br / > breast cancer < br / >< br / >< br / > < br / > have obvious genetic tendency: < br / > < br / > (1) family (including first and second degree relatives)First degree relatives refer to parents, children, brothers and sisters (the same parents); second degree relatives refer to the carriers with BRCA1 / BRCA2 gene mutations in uncles, uncles, aunts, grandparents and grandparents; < br / > < br / > (2) breast cancer patients in the family, the age of onset is before 45 years old; < br / > < br / > (3) two breast cancer patients in the family (one bilateral or two unilateral), The age of onset was 45-50 years old; < br / > < br / > (4) two or more people in the family had breast cancer, or ovarian cancer, or salpingal cancer, or primary peritoneal cancer; < br / > < br / > (5) there were male breast cancer patients in the family; < br / > < br / > (6) had breast cancer, or ovarian cancer, or salpingal cancer, or primary peritoneal cancer< br / >, It is recommended to maintain the screening for healthy people and those with life expectancy of more than 10 years, and to have mammography once every 1-2 years< br / >< br / >< br / > < br / > cervical cancer < br / >< br / >, Once every 3 years; or once every 5 years after the combination of high-risk HPV and cervical cytology screening without abnormality for 3 years in a row; < br / > < br / > end time of screening: > 65 years old and negative in previous multiple examinations, the screening will end; if the patient has been diagnosed with high squamous intraepithelial disease (HSIL), the screening will continue for another 20 years, The frequency of screening depends on the condition; < br / > < br / > women who have undergone total hysterectomy (no cervix), and who have not had cervical intraepithelial neoplasia (CIN) 2, CIN3, carcinoma in situ or cancer in the past 20 years, do not need to be examined; < br / > < br / > women who have been vaccinated with HPV follow the advice of specific age (the same as women who have not been vaccinated)< br / >< br / > < br / > lung cancer < br / >, Including less than 15 years of quitting smoking; < br / > < br / > passive smoking; < br / > < br / > occupational exposure history (asbestos, beryllium, uranium, radon and other contacts); < br / > < br / > family history of malignant tumor or lung cancer; < br / > family history of chronic obstructive pulmonary disease or diffuse pulmonary fibrosis< br / >It is recommended to use 64 or more rows of spiral CT for lung cancer screeningThe scanning range was from the tip of lung to the tip of costophrenic angleAfter baseline CT scan, according to the specific conditions of the focus (shape, size, boundary and other characteristics), it is recommended to consult the special hospital for specific diagnosis and treatment plan for the next step; < br / > < br / > if pulmonary nodules are detected, LDCT reexamination shall be carried out according to the specific conditions of ground glass, substantiality, solid nodules and multiple nodules according to the different characteristics of the nodules; < br / > < br / > according to the national conditions, efficiency and the characteristics of the Chinese population, PET / CT is not recommended as a screening method for lung cancer< br / >< br / >; < br / > < br / > patients with drug-induced liver damage; < br / > < br / > patients with hereditary metabolic diseases, including: hemochromatosis, α - 1 antitrypsin deficiency, glycogen storage disease, delayed skin porphyria, tyrosinemia and so on; < br / > < br / > patients with autoimmune hepatitis; < br / > < br / > patients with nonalcoholic fatty liver (NAFLD)< br / >< br / >< br / > < br / > gastric cancer < br / >, All of them were at high risk: < br / > < br / > over 60 years old; < br / > < br / > moderate and severe atrophic gastritis; < br / > < br / > chronic gastric ulcer; < br / > < br / > gastric polyp; < br / > < br / > giant folds of gastric mucosa; < br / > < br / > remnant stomach after operation of benign diseases; < br / > < br / > remnant stomach after operation of gastric cancer (6-12 months after operation); < br / > patients with Helicobacter pylori infection; < br / > < br / > family history of gastric cancer or esophageal cancer, < br / > pernicious anemia, < br / > family history of adenomatous polyposis (FAP) and hereditary nonpolyposis colon cancer (HNPCC)< br / >< br / >
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.